GPR21 and Obesity: TheseGpr21 KO mice were leaner than their wildtype littermate control (Osbornet al.) and were resistant to diet-induced obesity (Gardneret al., 2012), making GPR21 a potential drug target candidate for the treatment of diabetes and obesity.